Fertility Preservation in the Male Adolescent Patient

  • Ron Golan
  • James A. KashanianEmail author


Over 15,000 children develop cancer in the United States (US) each year (Ward et al., CA Cancer J Clin 64(2):83–103, 2014), with a 5-year survival rate for childhood cancer being roughly 80% (Robison and Hudson, Nat Rev Cancer 14(1):61–70, 2014). This extrapolates to over 385,000 childhood cancer survivors living in the United States (Phillips et al., Cancer Epidemiol Biomark Prev 24(4):653–663, 2015). With a growing number of childhood cancer survivors, oncologic counseling has seen a shift in focus from concentrating solely on short- and long-term survival benefits of treatment regimens to survivorship and long-term effects of treatments. With this shifting paradigm, short- and long-term gonadotoxic effects of cancer treatment have become a major concern for clinicians treating and patients diagnosed with malignancies. Because of this, fertility preservation (FP) among adolescent and young adult (AYA) cancer patients has become a significant area of interest and research.

In this chapter, we will discuss FP management options, outcomes, and expectations in the AYA patient population. Questions that will be addressed include barriers to FP, attitudes and perspectives of cancer survivors, short- and long-term effects of cancer treatment on spermatogenesis, quality of sperm in the setting of localized or systemic malignancies, optimal timing for FP, conventional and experimental options for FP, and utilization of sperm banked.


Fertility Fertility preservation Oncofertility Sperm banking Tissue cryopreservation Gonadotoxicity 


  1. 1.
    Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. Scholar
  2. 2.
    Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61–70. Scholar
  3. 3.
    Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, Alfano CM, Gibson TM, de Moor JS, Hartigan DB, Armstrong GT, Robison LL, Rowland JH, Oeffinger KC, Mariotto AB. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomark Prev. 2015;24(4):653–63. Scholar
  4. 4.
    Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10. Scholar
  5. 5.
    Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100(5):1224–31. Scholar
  6. 6.
    Botchan A, Karpol S, Lehavi O, Paz G, Kleiman SE, Yogev L, Yavetz H, Hauser R. Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center. Asian J Androl. 2013;15(3):382–6. Scholar
  7. 7.
    Moss JL, Choi AW, Fitzgerald Keeter MK, Brannigan RE. Male adolescent fertility preservation. Fertil Steril. 2016;105(2):267–73. Scholar
  8. 8.
    Munoz M, Santaballa A, Segui MA, Beato C, de la Cruz S, Espinosa J, Fonseca PJ, Perez J, Quintanar T, Blasco A. SEOM clinical guideline of fertility preservation and reproduction in cancer patients (2016). Clin Transl Oncol. 2016;18(12):1229–36. Scholar
  9. 9.
    Lewin J, Ma JMZ, Mitchell L, Tam S, Puri N, Stephens D, Srikanthan A, Bedard P, Razak A, Crump M, Warr D, Giuliani M, Gupta A. The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options. Support Care Cancer. 2017;25(6):1915–22. Scholar
  10. 10.
    Stein DM, Victorson DE, Choy JT, Waimey KE, Pearman TP, Smith K, Dreyfuss J, Kinahan KE, Sadhwani D, Woodruff TK, Brannigan RE. Fertility preservation preferences and perspectives among adult male survivors of pediatric cancer and their parents. J Adolesc Young Adult Oncol. 2014;3(2):75–82. Scholar
  11. 11.
    Zavras N, Siristatidis C, Siatelis A, Koumarianou A. Fertility risk assessment and preservation in male and female prepubertal and adolescent cancer patients. Clin Med Insights Oncol. 2016;10:49–57. Scholar
  12. 12.
    Stinson JN, Jibb LA, Greenberg M, Barrera M, Luca S, White ME, Gupta A. A qualitative study of the impact of cancer on romantic relationships, sexual relationships, and fertility: perspectives of Canadian adolescents and parents during and after treatment. J Adolesc Young Adult Oncol. 2015;4(2):84–90. Scholar
  13. 13.
    Diesch T, Rovo A, von der Weid N, Faraci M, Pillon M, Dalissier A, Dalle JH, Bader P. Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey. Bone Marrow Transplant. 2017;52(7):1022–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Fuchs A, Kashanian JA, Clayman ML, Gosiengfiao Y, Lockart B, Woodruff TK, Brannigan RE. Pediatric oncology providers’ attitudes and practice patterns regarding fertility preservation in adolescent male cancer patients. J Pediatr Hematol Oncol. 2016;38(2):118–22. Scholar
  15. 15.
    Nahata L, Ziniel SI, Garvey KC, Yu RN, Cohen LE. Fertility and sexual function: a gap in training in pediatric endocrinology. J Pediatr Endocrinol Metab. 2017;30(1):3–10. Scholar
  16. 16.
    Panagiotopoulou N, van Delft FW, Hale JP, Stewart JA. Fertility preservation care for children and adolescents with cancer: an inquiry to quantify professionals’ barriers. J Adolesc Young Adult Oncol. 2017;6(3):422–8. Scholar
  17. 17.
    Diesch T, von der Weid NX, Szinnai G, Schaedelin S, De Geyter C, Rovo A, Swiss Pediatric Oncology Group SPOG. Fertility preservation in pediatric and adolescent cancer patients in Switzerland: a qualitative cross-sectional survey. Cancer Epidemiol. 2016;44:141–6. Scholar
  18. 18.
    Goodwin T, Elizabeth Oosterhuis B, Kiernan M, Hudson MM, Dahl GV. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr Blood Cancer. 2007;48(1):80–5. Scholar
  19. 19.
    DiNofia AM, Wang X, Yannekis G, Ogle S, Hobbie WL, Carlson CA, Ginsberg JP. Analysis of semen parameters in a young cohort of cancer patients. Pediatr Blood Cancer. 2017;64(2):381–6. Scholar
  20. 20.
    Vadaparampil ST, Gwede CK, Meade C, Kelvin J, Reich RR, Reinecke J, Bowman M, Sehovic I, Quinn GP, ENRICH Research Group. ENRICH: a promising oncology nurse training program to implement ASCO clinical practice guidelines on fertility for AYA cancer patients. Patient Educ Couns. 2016;99(11):1907–10. Scholar
  21. 21.
    Tam S, Puri N, Stephens D, Mitchell L, Giuliani M, Papadakos J, Gupta AA. Improving access to standardized fertility preservation information for older adolescents and young adults with cancer: using a user-centered approach with young adult patients, survivors, and partners to refine fertility knowledge transfer. J Cancer Educ. 2016.
  22. 22.
    Li N, Jayasinghe Y, Kemertzis MA, Moore P, Peate M. Fertility preservation in pediatric and adolescent oncology patients: the decision-making process of parents. J Adolesc Young Adult Oncol. 2017;6(2):213–22. Scholar
  23. 23.
    Taylor JF, Ott MA. Fertility preservation after a cancer diagnosis: a systematic review of adolescents’, parents’, and providers’ perspectives, experiences, and preferences. J Pediatr Adolesc Gynecol. 2016;29(6):585–98. Scholar
  24. 24.
    Ellis SJ, Wakefield CE, McLoone JK, Robertson EG, Cohn RJ. Fertility concerns among child and adolescent cancer survivors and their parents: a qualitative analysis. J Psychosoc Oncol. 2016;34(5):347–62. Scholar
  25. 25.
    Klosky JL, Anderson LE, Russell KM, Huang L, Zhang H, Schover LR, Simmons JL, Kutteh WH. Provider influences on sperm banking outcomes among adolescent males newly diagnosed with cancer. J Adolesc Health. 2017;60(3):277–83. Scholar
  26. 26.
    Johnson MD, Cooper AR, Jungheim ES, Lanzendorf SE, Odem RR, Ratts VS. Sperm banking for fertility preservation: a 20-year experience. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):177–82. Scholar
  27. 27.
    Bizet P, Saias-Magnan J, Jouve E, Grillo JM, Karsenty G, Metzler-Guillemain C, Perrin J. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online. 2012;24(3):321–30. Scholar
  28. 28.
    Pereira ML, Garcia e Costa F. The blood-testis barrier as a target of some chemotherapeutic agents. Chemotherapy. 2007;53(6):446–8. Scholar
  29. 29.
    Masliukaite I, Hagen JM, Jahnukainen K, Stukenborg JB, Repping S, van der Veen F, van Wely M, van Pelt AM. Establishing reference values for age-related spermatogonial quantity in prepubertal human testes: a systematic review and meta-analysis. Fertil Steril. 2016;106(7):1652–7. e1652. Scholar
  30. 30.
    Smit M, van Casteren NJ, Wildhagen MF, Romijn JC, Dohle GR. Sperm DNA integrity in cancer patients before and after cytotoxic treatment. Hum Reprod. 2010;25(8):1877–83. Scholar
  31. 31.
    Gandini L, Lombardo F, Salacone P, Paoli D, Anselmo AP, Culasso F, Dondero F, Lenzi A. Testicular cancer and Hodgkin’s disease: evaluation of semen quality. Hum Reprod. 2003;18(4):796–801.CrossRefPubMedGoogle Scholar
  32. 32.
    Said TM, Tellez S, Evenson DP, Del Valle AP. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies. Andrologia. 2009;41(6):377–82. Scholar
  33. 33.
    Hallak J, Kolettis PN, Sekhon VS, Thomas AJ Jr, Agarwal A. Sperm cryopreservation in patients with testicular cancer. Urology. 1999;54(5):894–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Girasole CR, Cookson MS, Smith JA Jr, Ivey BS, Roth BJ, Chang SS. Sperm banking: use and outcomes in patients treated for testicular cancer. BJU Int. 2007;99(1):33–6. Scholar
  35. 35.
    Pacey A, Merrick H, Arden-Close E, Morris K, Rowe R, Stark D, Eiser C. Implications of sperm banking for health-related quality of life up to 1 year after cancer diagnosis. Br J Cancer. 2013;108(5):1004–11. Scholar
  36. 36.
    Navarro Medina P, Barroso Deyne E, Castillo Suarez M, Blanco Diez A, Lozano M, Artiles Hernandez JL, Chesa Ponce N. An analysis of our experience in cryopreservation of semen from cancer patients. Actas Urol Esp. 2010;34(1):101–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer. 2003;97(7):1624–9. Scholar
  38. 38.
    Ferrari S, Paffoni A, Filippi F, Busnelli A, Vegetti W, Somigliana E. Sperm cryopreservation and reproductive outcome in male cancer patients: a systematic review. Reprod Biomed Online. 2016;33(1):29–38. Scholar
  39. 39.
    Choi BB, Goldstein M, Moomjy M, Palermo G, Rosenwaks Z, Schlegel PN. Births using sperm retrieved via immediate microdissection of a solitary testis with cancer. Fertil Steril. 2005;84(5):1508. Scholar
  40. 40.
    Bujan L, Walschaerts M, Moinard N, Hennebicq S, Saias J, Brugnon F, Auger J, Berthaut I, Szerman E, Daudin M, Rives N. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network. Fertil Steril. 2013;100(3):673–80. Scholar
  41. 41.
    van Casteren NJ, Boellaard WP, Romijn JC, Dohle GR. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl. 2010;33(1):73–9. Scholar
  42. 42.
    Crha I, Ventruba P, Zakova J, Huser M, Kubesova B, Hudecek R, Jarkovsky J. Survival and infertility treatment in male cancer patients after sperm banking. Fertil Steril. 2009;91(6):2344–8. Scholar
  43. 43.
    Molnar Z, Benyo M, Bazsane Kassai Z, Levai I, Varga A, Jakab A. Influence of malignant tumors occurring in the reproductive age on spermiogenesis: studies on patients with testicular tumor and lymphoma. Orv Hetil. 2014;155(33):1306–11. Scholar
  44. 44.
    Zakova J, Lousova E, Ventruba P, Crha I, Pochopova H, Vinklarkova J, Tesarova E, Nussir M. Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility. Sci World J. 2014;2014:575978. Scholar
  45. 45.
    Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 2003;200(3):370–4. Scholar
  46. 46.
    Rives N, Perdrix A, Hennebicq S, Saias-Magnan J, Melin MC, Berthaut I, Barthelemy C, Daudin M, Szerman E, Bresson JL, Brugnon F, Bujan L. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French national CECOS network. J Androl. 2012;33(6):1394–401. Scholar
  47. 47.
    Puhse G, Secker A, Kemper S, Hertle L, Kliesch S. Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. Int J Androl. 2011;34(5 Pt 2):e351–7. Scholar
  48. 48.
    Lackner JE, Koller A, Schatzl G, Marberger M, Kratzik C. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy. Urology. 2009;74(4):825–9. Scholar
  49. 49.
    O'Carrigan B, Fournier M, Olver IN, Stockler MR, Whitford H, Toner GC, Thomson DB, Davis ID, Hanning F, Singhal N, Underhill C, Clingan P, McDonald A, Boland A, Grimison P. Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study. Intern Med J. 2014;44(8):813–7. Scholar
  50. 50.
    Sprauten M, Brydoy M, Haugnes HS, Cvancarova M, Bjoro T, Bjerner J, Fossa SD, Oldenburg J. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. J Clin Oncol. 2014;32(6):571–8. Scholar
  51. 51.
    Wasilewski-Masker K, Seidel KD, Leisenring W, Mertens AC, Shnorhavorian M, Ritenour CW, Stovall M, Green DM, Sklar CA, Armstrong GT, Robison LL, Meacham LR. Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study. J Cancer Surviv. 2014;8(3):437–47. Scholar
  52. 52.
    Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA, Chemaitilly W, Pui CH, Klosky JL, Spunt SL, Metzger ML, Srivastava D, Ness KK, Robison LL, Hudson MM. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude lifetime cohort study. Lancet Oncol. 2014;15(11):1215–23. Scholar
  53. 53.
    Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update. 2001;7(4):363–9.CrossRefPubMedGoogle Scholar
  54. 54.
    De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R, Bujan L. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod. 2001;16(6):1204–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E, Giwercman A. Sperm DNA integrity in testicular cancer patients. Hum Reprod. 2006;21(12):3199–205. Scholar
  56. 56.
    Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin’s lymphoma patients. Hum Reprod. 2008;23(2):251–8. Scholar
  57. 57.
    Paoli D, Gallo M, Rizzo F, Spano M, Leter G, Lombardo F, Lenzi A, Gandini L. Testicular cancer and sperm DNA damage: short- and long-term effects of antineoplastic treatment. Andrology. 2014;3(1):122–8. Scholar
  58. 58.
    Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E, Giwercman A. The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer. 2004;100(6):1137–44. Scholar
  59. 59.
    Ribeiro TM, Bertolla RP, Spaine DM, Fraietta R, Ortiz V, Cedenho AP. Sperm nuclear apoptotic DNA fragmentation in men with testicular cancer. Fertil Steril. 2008;90(5):1782–6. Scholar
  60. 60.
    Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet. 2002;360(9330):361–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100(5):1180–6. Scholar
  62. 62.
    Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15(6):608–13.PubMedGoogle Scholar
  63. 63.
    Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.CrossRefPubMedGoogle Scholar
  64. 64.
    Anserini P, Chiodi S, Spinelli S, Costa M, Conte N, Copello F, Bacigalupo A. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002;30(7):447–51. Scholar
  65. 65.
    Bang AK, Petersen JH, Petersen PM, Andersson AM, Daugaard G, Jorgensen N. Testosterone production is better preserved after 16 than 20 gray irradiation treatment against testicular carcinoma in situ cells. Int J Radiat Oncol Biol Phys. 2009;75(3):672–6. Scholar
  66. 66.
    Brenner J, Vugrin D, Whitmore WF Jr. Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis. Am J Clin Oncol. 1985;8(2):178–82.CrossRefPubMedGoogle Scholar
  67. 67.
    Fossa SD, Ous S, Abyholm T, Loeb M. Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol. 1985;57(2):204–9.CrossRefPubMedGoogle Scholar
  68. 68.
    Fritz K, Weissbach L. Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertil Steril. 1985;43(3):451–4.CrossRefPubMedGoogle Scholar
  69. 69.
    Beck SD, Bey AL, Bihrle R, Foster RS. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol. 2010;184(5):2078–80. Scholar
  70. 70.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German testicular cancer study group. J Urol. 2003;169(5):1710–4. Scholar
  71. 71.
    Steiner H, Peschel R, Janetschek G, Holtl L, Berger AP, Bartsch G, Hobisch A. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology. 2004;63(3):550–5. Scholar
  72. 72.
    Pettus JA, Carver BS, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009;73(2):328–31. discussion 331–322. Scholar
  73. 73.
    Hsiao W, Deveci S, Mulhall JP. Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation. BJU Int. 2012;110(8):1196–200. Scholar
  74. 74.
    Hermo L, Pelletier RM, Cyr DG, Smith CE. Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: background to spermatogenesis, spermatogonia, and spermatocytes. Microsc Res Tech. 2010;73(4):241–78. Scholar
  75. 75.
    Berookhim BM, Mulhall JP. Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment. Fertil Steril. 2014;101(3):805–11. Scholar
  76. 76.
    Choy JT, Wiser HJ, Bell SW, Cashy J, Brannigan RE, Kohler TS. Predictors of spermatogenesis in orchiectomy specimens. Urology. 2013;81(2):288–92. Scholar
  77. 77.
    Descombe L, Chauleur C, Gentil-Perret A, Aknin-Seifer I, Tostain J, Levy R. Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case report. Fertil Steril. 2008;90(2):443.e441–4. Scholar
  78. 78.
    Furuhashi K, Ishikawa T, Hashimoto H, Yamada S, Ogata S, Mizusawa Y, Matsumoto Y, Okamoto E, Kokeguchi S, Shiotani M. Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients. Andrologia. 2013;45(2):107–10. Scholar
  79. 79.
    Haddad N, Al-Rabeeah K, Onerheim R, Zini A. Is ex vivo microdissection testicular sperm extraction indicated for infertile men undergoing radical orchiectomy for testicular cancer? Case report and literature review. Fertil Steril. 2014;101(4):956–9. Scholar
  80. 80.
    Ho C, Zacharin M. Fertility preservation in an adolescent boy: inducing puberty and spermatogenesis prior to elective, non-urgent bone marrow transplantation. Bone Marrow Transplant. 2017;52(5):792–3. Scholar
  81. 81.
    Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? A multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clin Endocrinol. 2017;86(1):75–87. Scholar
  82. 82.
    Onofre J, Baert Y, Faes K, Goossens E. Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation. Hum Reprod Update. 2016;22(6):744–61. Scholar
  83. 83.
    Goossens E, Frederickx V, Geens M, De Block G, Tournaye H. Cryosurvival and spermatogenesis after allografting prepubertal mouse tissue: comparison of two cryopreservation protocols. Fertil Steril. 2008;89(3):725–7. Scholar
  84. 84.
    Watson PF. Recent developments and concepts in the cryopreservation of spermatozoa and the assessment of their post-thawing function. Reprod Fertil Dev. 1995;7(4):871. Scholar
  85. 85.
    Vermeulen M, Poels J, de Michele F, des Rieux A, Wyns C. Restoring fertility with cryopreserved Prepubertal testicular tissue: perspectives with hydrogel encapsulation, nanotechnology, and bioengineered scaffolds. Ann Biomed Eng. 2017;45(7):1770–81. Scholar
  86. 86.
    Yango P, Altman E, Smith JF, Klatsky PC, Tran ND. Optimizing cryopreservation of human spermatogonial stem cells: comparing the effectiveness of testicular tissue and single cell suspension cryopreservation. Fertil Steril. 2014;102(5):1491–1498.e1491. Scholar
  87. 87.
    Gouk SS, Loh YFJ, Kumar SD, Watson PF, Kuleshova LL. Cryopreservation of mouse testicular tissue: prospect for harvesting spermatogonial stem cells for fertility preservation. Fertil Steril. 2011;95(7):2399–403. Scholar
  88. 88.
    Honaramooz A, Snedaker A, Boiani M, Schöler H, Dobrinski I, Schlatt S. Sperm from neonatal mammalian testes grafted in mice. Nature. 2002;418(6899):778–81. Scholar
  89. 89.
    Jahnukainen K, Ehmcke J, Nurmio M, Schlatt S. Autologous ectopic grafting of cryopreserved testicular tissue preserves the fertility of prepubescent monkeys that receive sterilizing cytotoxic therapy. Cancer Res. 2012;72(20):5174–8. Scholar
  90. 90.
    Nakai M, Kaneko H, Somfai T, Maedomari N, Ozawa M, Noguchi J, Ito J, Kashiwazaki N, Kikuchi K. Production of viable piglets for the first time using sperm derived from ectopic testicular xenografts. Reproduction. 2010;139(2):331–5. Scholar
  91. 91.
    Schlatt S, Honaramooz A, Boiani M, Schöler HR, Dobrinski I. Progeny from sperm obtained after ectopic grafting of neonatal mouse testes. Biol Reprod. 2003;68(6):2331–5. Scholar
  92. 92.
    Goossens E, Geens M, De Block G, Tournaye H. Spermatogonial survival in long-term human prepubertal xenografts. Fertil Steril. 2008;90(5):2019–22. Scholar
  93. 93.
    Wyns C, Van Langendonckt A, Wese F-X, Donnez J, Curaba M. Long-term spermatogonial survival in cryopreserved and xenografted immature human testicular tissue. Hum Reprod. 2008;23(11):2402–14. Scholar
  94. 94.
    Kimsa MC, Strzalka-Mrozik B, Kimsa MW, Gola J, Nicholson P, Lopata K, Mazurek U. Porcine endogenous retroviruses in xenotransplantation—molecular aspects. Virus. 2014;6(5):2062–83. Scholar
  95. 95.
    Gassei K, Orwig KE. Experimental methods to preserve male fertility and treat male factor infertility. Fertil Steril. 2016;105(2):256–66. Scholar
  96. 96.
    Zhang R, Sun J, Zou K. Advances in isolation methods for spermatogonial stem cells. Stem Cell Rev. 2016;12(1):15–25. Scholar
  97. 97.
    Sadri-Ardekani H, Homburg CH, van Capel TMM, van den Berg H, van der Veen F, van der Schoot CE, van Pelt AMM, Repping S. Eliminating acute lymphoblastic leukemia cells from human testicular cell cultures: a pilot study. Fertil Steril. 2014;101(4):1072–1078.e1071. Scholar
  98. 98.
    Dovey SL, Valli H, Hermann BP, Sukhwani M, Donohue J, Castro CA, Chu T, Sanfilippo JS, Orwig KE. Eliminating malignant contamination from therapeutic human spermatogonial stem cells. J. Clin Investig. 2013;123(4):1833–43.CrossRefPubMedGoogle Scholar
  99. 99.
    Langenstroth D, Kossack N, Westernströer B, Wistuba J, Behr R, Gromoll J, Schlatt S. Separation of somatic and germ cells is required to establish primate spermatogonial cultures. Hum Reprod. 2014;29(9):2018–31. Scholar
  100. 100.
    Sadri-Ardekani H, Mizrak SC, van Daalen SKM, Korver CM, Roepers-Gajadien HL, Koruji M, Hovingh S, de Reijke TM, de la Rosette JJMCH, van der Veen F, de Rooij DG, Repping S, van Pelt AMM. Propagation of human spermatogonial stem cells in vitro. JAMA. 2009;302(19):2127–34. Scholar
  101. 101.
    Giudice MG, de Michele F, Poels J, Vermeulen M, Wyns C. Update on fertility restoration from prepubertal spermatogonial stem cells: how far are we from clinical practice? Stem Cell Res. 2017;21:171–7. Scholar
  102. 102.
    Sato T, Katagiri K, Gohbara A, Inoue K, Ogonuki N, Ogura A, Kubota Y, Ogawa T. In vitro production of functional sperm in cultured neonatal mouse testes. Nature. 2011;471(7339):504–7. Scholar
  103. 103.
    Fattahi A, Latifi Z, Ghasemnejad T, Nejabati HR, Nouri M. Insights into in vitro spermatogenesis in mammals: past, present, future. Mol Reprod Dev. 2017;84(7):560–75. Scholar
  104. 104.
    Honaramooz A, Megee SO, Rathi R, Dobrinski I. Building a testis: formation of functional testis tissue after transplantation of isolated porcine (Sus scrofa) testis cells. Biol Reprod. 2007;76(1):43–7. Scholar
  105. 105.
    Gassei K, Schlatt S, Ehmcke J. De novo morphogenesis of seminiferous tubules from dissociated immature rat testicular cells in xenografts. J Androl. 2006;27(4):611–8. Scholar
  106. 106.
    Baert Y, De Kock J, Alves-Lopes JP, Söder O, Stukenborg J-B, Goossens E. Primary human testicular cells self-organize into organoids with testicular properties. Stem Cell Rep. 2017;8(1):30–8. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of UrologyWeill Cornell MedicineNew YorkUSA

Personalised recommendations